Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives by doing so. But nearly a third of the medicines aren't new or were repurposed many times for financial gain.
Read more on NPR
Health Care - January 17, 2017 at 04:59PM - Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies
Không có nhận xét nào:
Đăng nhận xét